Zepbound Price by Dose 2026: LillyDirect vs Pharmacy vs Insurance
Key Takeaways
- Zepbound's list price is ~$1,086/month for pre-filled pens — but LillyDirect vials start at $299/month
- LillyDirect's Self Pay Journey Program caps maintenance doses (7.5–15 mg) at $449/month — but only if you refill within 45 days
- Miss the 45-day refill window and higher-dose prices jump to $499–$699/month
- Medicare GLP-1 Bridge covers Zepbound KwikPen at $50/month — but single-dose vials and pens are excluded
- With commercial insurance + Lilly savings card, eligible patients pay as low as $25/month
Zepbound (tirzepatide) is a dual GIP/GLP-1 receptor agonist — it works on two hunger-signaling pathways instead of one, which clinical trials have shown produces roughly 5–7% more weight loss than semaglutide alone. It's also one of the most expensive GLP-1 medications at list price.
But what you actually pay in 2026 depends almost entirely on which access pathway you use. Here's every Zepbound price point, broken down by dose, with the details that most pricing guides leave out.
LillyDirect Self-Pay: The Real Cash Price
LillyDirect is Eli Lilly's direct-to-consumer pharmacy platform. It is currently the cheapest legal source of brand-name Zepbound without insurance. The medication ships as single-dose vials (you draw up the dose with a syringe) or KwikPen multi-dose pens — both are priced the same through the self-pay program.
| Dose | LillyDirect Price | Regular Price (if 45-day lapse) | Retail Pen List Price |
|---|---|---|---|
| 2.5 mg (starter) | $299/mo | $299 (no change) | $1,086 |
| 5 mg | $399/mo | $399 (no change) | $1,086 |
| 7.5 mg | $449/mo | $499 | $1,086 |
| 10 mg | $449/mo | $699 | $1,086 |
| 12.5 mg | $449/mo | $699 | $1,086 |
| 15 mg (max) | $449/mo | $699 | $1,086 |
One month = 28 days (4 weekly doses). Prices effective February 23, 2026. Verified via lilly.com and LillyDirect, July 2026.
The $449/month price on doses 7.5 mg and above only holds while you stay in the Zepbound Self Pay Journey Program. To remain enrolled, you must complete your refill purchase within 45 days of the delivery date of your previous order. Miss this window and the regular price kicks in — up to $699/month for the highest doses. Set a calendar reminder for day 30. The 45-day buffer exists for shipping delays, not forgetting.
Insurance Coverage + Savings Card
If your commercial insurance plan covers Zepbound, Eli Lilly's savings card can bring your out-of-pocket cost down to as little as $25/month for the pre-filled single-dose pens. The card provides up to $100 in monthly savings ($1,300 annual cap).
If your commercial plan doesn't cover Zepbound: The savings card still helps — it can cap your cost at $499/month for single-dose pens at retail pharmacies. That's less than LillyDirect for higher doses, but more than the $449 Journey Program price through LillyDirect for 7.5 mg and above.
Important format distinction: Insurance coverage (and the savings card) typically applies to pre-filled single-dose pens at retail pharmacies. LillyDirect's self-pay program uses single-dose vials (requiring a syringe draw-up) or the newer KwikPen (multi-dose pen). These are different form factors — discuss with your provider which you prefer.
Medicare GLP-1 Bridge: $50/Month (With Restrictions)
The Medicare GLP-1 Bridge covers Zepbound at $50/month for qualifying beneficiaries, starting July 1, 2026 through December 31, 2027.
Only the Zepbound KwikPen multi-dose formulation is covered under the Bridge. Single-dose vials and standard single-dose pens are excluded. Your prescriber needs to write for the KwikPen specifically. Same BMI eligibility tiers as Wegovy: BMI ≥ 35, or BMI 30+ with comorbidity, or BMI 27+ with specific cardiovascular conditions.
TrumpRx.gov: Federal Cash-Price Option
The TrumpRx.gov platform also offers Zepbound at reduced cash prices through Most-Favored-Nation pricing agreements with Eli Lilly. As of July 2026, Zepbound is listed at approximately $346/month on average, with entry-level options around $299/month.
This is competitive with — and in some cases slightly better than — LillyDirect pricing for lower doses, though the exact price you pay may vary. No insurance is required.
Compounded Tirzepatide: The Budget Tier
Compounded tirzepatide from telehealth providers is the least expensive access point. These are pharmacy-prepared formulations using the same active ingredient but prepared by 503A compounding pharmacies based on individual prescriptions.
Compounded tirzepatide is not FDA-approved. It has not been evaluated for safety, efficacy, or manufacturing quality by the FDA. It is not the same as Zepbound. The legal status of compounded tirzepatide depends on the FDA's ongoing 503B bulks-list rulemaking, which has not been finalized as of July 2026.
Injectable tirzepatide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
Injectable tirzepatide
Compounded medications are prepared by pharmacies and are not FDA-approved. They have not been evaluated for safety, efficacy, or manufacturing quality by the FDA.
Check Current Pricing →Paid link · We may earn a commission
12-Month Cost Comparison by Pathway
Treatment with tirzepatide involves dose escalation: you start at 2.5 mg and increase every 4 weeks until you reach a maintenance dose (typically 10–15 mg). This means your monthly cost changes over time. Here's what a full year looks like under different scenarios:
| Pathway | Months 1–2 (2.5–5 mg) | Months 3–12 (7.5–15 mg) | 12-Month Total |
|---|---|---|---|
| Medicare Bridge | $50/mo | $50/mo | $600 |
| Insurance + savings card | $25/mo | $25/mo | $300 |
| Compounded (GobyMeds) | $133/mo | $133/mo | $1,596 |
| LillyDirect self-pay | $299–$399 | $449/mo | $5,188 |
| Retail pens (no discounts) | $1,086/mo | $1,086/mo | $13,032 |
Estimates assume standard dose escalation. Actual costs depend on titration speed, which dose you maintain on, and whether pricing programs remain in effect. Compounded pricing assumes GobyMeds tirzepatide at advertised rate.
Pharmacy vs. LillyDirect vs. Insurance: Decision Matrix
You have commercial insurance that covers Zepbound → Use the Lilly savings card at a retail pharmacy. You'll pay $25/month, which is the cheapest legitimate pathway to brand-name tirzepatide.
You have commercial insurance but it doesn't cover Zepbound → Compare LillyDirect self-pay ($299–$449/month) against the non-covered savings card at retail ($499/month for pens). LillyDirect wins for maintenance doses.
You have Medicare and qualify for the Bridge → The $50/month KwikPen through the Bridge Program is the clear winner. Make sure your prescription specifies the KwikPen formulation.
You're uninsured → LillyDirect self-pay ($299–$449/month) for brand-name, or compounded tirzepatide ($40–$133/month) if you're comfortable with a non-FDA-approved formulation. Set your 45-day refill reminders if using LillyDirect.
Zepbound at full retail ($1,086/month) is a number almost no one should be paying in 2026. Between LillyDirect, the Medicare Bridge, savings cards, and compounded alternatives, the actual cost of tirzepatide for weight loss ranges from $25 to $449 per month. The key is matching the right program to your insurance status — and if you're on LillyDirect, never missing that 45-day refill window.
Prices verified as of July 15, 2026. LillyDirect and manufacturer savings programs may change. Always confirm current pricing directly with LillyDirect, your pharmacy, or your insurance before starting treatment.